癌症登記軟體的全球市場:現狀分析與預測(2022年～2028年)

Cancer Registry Software Market: Current Analysis and Forecast (2022-2028)

出版日期: 2023年02月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 163 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球癌症登記軟體的市場規模，在預測期間內(2022年～2028年)預計以約10.5％的年複合成長率成長。市場成長的主要促進因素之一，是在全球的癌症發生率增加。

本報告提供全球癌症登記軟體市場相關調查分析，市場動態，趨勢與機會，企業簡介等資訊。

The Cancer Registry Software Market is expected to witness a CAGR of around 10.5% during the forecast period i.e., 2022-2028. Cancer registry software is a database or information system that helps collect information about cancer patients. One of the key factors driving the growth of the global cancer registry software market is the increasing incidence of cancer across the globe. For instance, according to the California Institute for Regenerative Medicine (CIRM) prostate cancer is the second leading cause of cancer death among men in the U.S., with a 60% occurrence rate in men over the age of 65. Approximately 61,860 patients are expected to die from prostate cancer in California in the year 2021. Cancer registry software helps track and monitor the health status of patients suffering from cancer. Data collected using cancer registry software helps researchers and doctors develop therapies to treat cancer. Therefore, the global cancer registry software market is expected to grow in the coming years.

In addition, the rising geriatric population is also boosting the growth of the cancer registry software market during the forecast period. Data collected by cancer registry software helps stop the spread of cancer around the world. The software also helps governments track patients in specific locations and regions. As a result, this factor is supporting the growth of the global cancer registry software market.

Based on type, the market is segmented into standalone and integration. The standalone segment is expected to grow significantly during the forecast period. Standalone cancer registry software integrated with the latest and most advanced features. It is also easy to use and operate. Standalone cancer registry software also helps reduce overhead. Therefore, all these factors are driving the growth of the segment.

On the basis of deployment, the market is bifurcated into on-premises and cloud. The on-premise segment dominated the cancer registry software market in 2020. On-premise cancer registry software is primarily used by research institutions that conduct cancer research. On-premise cancer registry software offers advanced features for easy data storage such as security and easy accessibility. On-premise cancer registry software is less risky compared to other types of models. As such, on-premise cancer registry software is widely used in hospitals and research centers.

Based on the functionality the market is segmented into cancer reporting, patient care, medical research, and others. The patient care segment is expected to grow significantly during the forecast period. Patient care management is a program that includes a variety of healthcare services that help patients monitor their condition, from primary care such as scheduling appointments to short-term case management and chronic illness management. The growing number of cancer patients is attributed to the segment growth during the forecast period.

Based on end-user, the market is segmented into government, private players, hospitals, biotech pharma, and others. The government sector dominated the cancer registry software market in 2021. Governments in established and emerging countries have adopted cancer registry software on a large scale. This software helps track and monitor cancer patients in their respective regions. Added to this is government investment in implementing cancer registry software in hospitals. These factors are expected to boost of the global cancer registry software market during the forecast period.

For a better understanding of the market adoption of the cancer registry software industry, the market is analyzed based on its worldwide presence in the countries such as North America (The U.S., Canada, Rest of North America), Europe (Germany, The U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American region is leading the cancer registry software market and is expected to maintain this during the forecast period. The presence of key market players is expected to propel the cancer registry software market in the region. Furthermore, government-funded efforts to support the development of cancer registries, and heavy investment in healthcare IT, are expected to significantly influence the market during the anticipation period. Moreover, the growing number of cancer patients in the region is also expected to drive the market during the analysis time period.

Some of the major players operating in the market include: Rocky Mountain Cancer Centers, MCKESSON CORPORATION, Netdox Health Pvt. Ltd, Elekta, IBM, C-Net Solutions, Ordinal Data Inc., Omega Healthcare, Energy & Resource Solutions, and Conduent, Inc.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Cancer Registry Software Market
2.2. Research Methodology of the Cancer Registry Software Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CANCER REGISTRY SOFTWARE MARKET

6 CANCER REGISTRY SOFTWARE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

7.1. Standalone
7.2. Integration

8 MARKET INSIGHTS BY DEPLOYMENT

8.1. Cloud
8.2. On-Premises

9 MARKET INSIGHTS BY FUNCTIONALITY

9.1. Cancer Reporting
9.2. Patient Care
9.3. Medical Research
9.4. Others

10 MARKET INSIGHTS BY END-USER

10.1. Government
10.2. Private Players
10.3. Hospitals
10.4. Biotech Pharma
10.5. Others

11 MARKET INSIGHTS BY REGION

11.1. North America
- 11.1.1. U.S.
- 11.1.2. Canada
- 11.1.3. Rest of North America
11.2. Europe
- 11.2.1. Germany
- 11.2.2. The U.K.
- 11.2.3. France
- 11.2.4. Italy
- 11.2.5. Spain
- 11.2.6. Rest of Europe
11.3. Asia-Pacific
- 11.3.1. China
- 11.3.2. Japan
- 11.3.3. India
- 11.3.4. Rest of Asia-Pacific
11.4. Rest of World